Search results
Illumina, Inc. (NASDAQ:ILMN) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoIllumina, Inc. (NASDAQ:ILMN) Q4 2023 Earnings Call Transcript February 8, 2024 Illumina, Inc. beats...
Illumina Inc CEO Jacob Thaysen Acquires 7,330 Shares
GuruFocus.com via Yahoo Finance· 3 months agoOn February 22, 2024, Jacob Thaysen, CEO of Illumina Inc (NASDAQ:ILMN), made a significant insider purchase, acquiring 7,330 shares of the company's...
Ravgen settles patent fight with Illumina over genetic testing
Reuters via Yahoo Finance· 1 year agoGene-sequencing giant Illumina Inc has settled a patent lawsuit brought by Maryland biotech company...
Should You Buy Illumina (ILMN) Ahead of Earnings?
Zacks via Yahoo Finance· 2 years agoInvestors are always looking for stocks that are poised to beat at earnings season and Illumina, Inc. ILMN may be one such company. The firm has earnings...
With 88% ownership, Illumina, Inc. (NASDAQ:ILMN) boasts of strong institutional backing
Simply Wall St. via Yahoo Finance· 2 years agoA look at the shareholders of Illumina, Inc. (NASDAQ:ILMN) can tell us which group is most powerful....
Is Illumina, Inc. (NASDAQ:ILMN) Trading At A 44% Discount?
Simply Wall St. via Yahoo Finance· 7 months agoKey Insights Illumina's estimated fair value is US$232 based on 2 Stage Free Cash Flow to Equity...
Is Illumina (ILMN) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap
GuruFocus.com via Yahoo Finance· 8 months agoValue-focused investors are always on the hunt for stocks that are priced below their intrinsic...
Illumina CEO survived Icahn's challenge by more than 2-to-1 margin
Reuters via Yahoo Finance· 12 months agoIllumina Inc CEO Francis deSouza survived a challenge to his board seat from activist investor Carl...
Here's Why Investors Should Retain Illumina (ILMN) Stock Now
Zacks via Yahoo Finance· 2 years agoIllumina, Inc. ILMN has been gaining from strength across its operating segments. The company...
Illumina Inks AI Pact With AstraZeneca To Accelerate Drug Target Discovery
Benzinga via Yahoo Finance· 2 years agoIllumina Inc (NASDAQ: ILMN) entered a strategic research collaboration with AstraZeneca plc (NASDAQ:...